$33.24 B
Share price
Change (1 day)
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Market capitalization of Biogen (BIIB)

Market cap: $33.24 Billion

As of July 2024 Biogen has a market cap of $33.24 Billion. This makes Biogen the world's 604th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Biogen from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024$33.24 B-11.34%
2023$37.49 B-5.97%
2022$39.87 B13.15%
2021$35.24 B-6.47%
2020$37.67 B-27.11%
2019$51.69 B-12.89%
2018$59.34 B-11.92%
2017$67.37 B9.19%
2016$61.69 B-7.87%
2015$66.96 B-15.89%
2014$79.62 B20.51%
2013$66.07 B90.8%
2012$34.62 B29.53%
2011$26.73 B65.75%
2010$16.12 B9.68%
2009$14.70 B7.18%
2008$13.71 B-18.49%
2007$16.83 B1.49%
2006$16.58 B7.9%
2005$15.36 B-32.09%
2004$22.63 B

End of Day market cap according to different sources

On Jul 17th, 2024 the market cap of Biogen was reported to be:

$33.24 Billion
by Yahoo Finance info icon info icon
$33.24 Billion
by CompaniesMarketCap info icon info icon
$33.24 Billion
by Nasdaq info icon info icon
$33.24 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$180.06 B 441.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$91.32 B 174.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$309.50 B 831.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$170.16 B 411.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$376.83 B 1,033.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.82 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$125.62 B 277.90%๐Ÿ‡ซ๐Ÿ‡ท France
$8.91 B-73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.09 B-42.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.42 B-71.65%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands